N21: The interpretation of thiopurine metabolites in clinical practice: IBD nurses experience in three North West England NHS trusts
ECCO '19 Copenhagen
2019
1
N23: IBD patients experience of the care given at the Stockholm Gastro Centre
ECCO '19 Copenhagen
2019
1
N24: Experience with Ustekinumab (STELARA®) in Paediatric inflammatory bowel disease (pIBD) – A case series
ECCO '19 Copenhagen
2019
1
OP01: In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease
ECCO '19 Copenhagen
2019
OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s disease
ECCO '19 Copenhagen
2019
OP04: Turning sweet in inflammatory bowel disease: glycans as novel immunomodulators of T-cell-mediated immune response
ECCO '19 Copenhagen
2019
OP06: Gut–brain axis revisited: Shedding light on the mucosa-associated microbial composition in IBD patients with psychological distress, anxiety, and depression
ECCO '19 Copenhagen
2019
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
ECCO '19 Copenhagen
2019
OP08: Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
ECCO '19 Copenhagen
2019
OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
ECCO '19 Copenhagen
2019
OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
ECCO '19 Copenhagen
2019
OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo culture
ECCO '19 Copenhagen
2019
OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptake
ECCO '19 Copenhagen
2019
OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study
ECCO '19 Copenhagen
2019
OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
ECCO '19 Copenhagen
2019